Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Relationship Between EPO Resistance and Sirtuin-1 Levels in Hemodialysis Patients.

NCT06877286 is registered in ClinicalTrials.gov with Cuma Bulent Gul as lead sponsor.

NCT NCT06877286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06877286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Relationship Between EPO Resistance and Sirtuin-1 Levels in Hemodialysis Patients.
Lead sponsor
Cuma Bulent Gul
Phase
Observational
Overall status
Completed
Start date
August 1, 2020
Completion date
October 15, 2021
Enrollment
391 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia in end stage renal disease, chronic kidney disease, erythropoietin, hemodialysis